Adverse events558

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 558

Type	Event	Organ system	Group	Affected	At risk	Events
other	QTc prolongation	Cardiac disorders	Standard Arm (Arm A) - Chemotherapy Phase	0	41	0
other	QTc prolongation	Cardiac disorders	First Experimental Arm (Arm B) - Chemotherapy Phase	3	42	3
other	QTc prolongation	Cardiac disorders	Second Experimental Arm (Arm C) - Chemotherapy Phase	0	39	0
other	QTc prolongation	Cardiac disorders	Standard Arm (Arm A) - Maintenance Phase	0	32	0
other	QTc prolongation	Cardiac disorders	First Experimental Arm (Arm B) - Maintenance Phase	0	26	0
other	QTc prolongation	Cardiac disorders	Second Experimental Arm (Arm C) - Maintenance Phase	0	17	0
other	abdominal cramping	General disorders	Standard Arm (Arm A) - Chemotherapy Phase	3	41	3
other	abdominal cramping	General disorders	First Experimental Arm (Arm B) - Chemotherapy Phase	0	42	0
other	abdominal cramping	General disorders	Second Experimental Arm (Arm C) - Chemotherapy Phase	1	39	1
other	abdominal cramping	General disorders	Standard Arm (Arm A) - Maintenance Phase	0	32	0
other	abdominal cramping	General disorders	First Experimental Arm (Arm B) - Maintenance Phase	0	26	0
other	abdominal cramping	General disorders	Second Experimental Arm (Arm C) - Maintenance Phase	0	17	0
other	Abdominal pain	General disorders	Standard Arm (Arm A) - Chemotherapy Phase	2	41	2
other	Abdominal pain	General disorders	First Experimental Arm (Arm B) - Chemotherapy Phase	4	42	4
other	Abdominal pain	General disorders	Second Experimental Arm (Arm C) - Chemotherapy Phase	3	39	3
other	Abdominal pain	General disorders	Standard Arm (Arm A) - Maintenance Phase	0	32	0
other	Abdominal pain	General disorders	First Experimental Arm (Arm B) - Maintenance Phase	0	26	0
other	Abdominal pain	General disorders	Second Experimental Arm (Arm C) - Maintenance Phase	0	17	0
other	Allergic reaction to Carboplatin	Immune system disorders	Standard Arm (Arm A) - Chemotherapy Phase	6	41	6
other	Allergic reaction to Carboplatin	Immune system disorders	First Experimental Arm (Arm B) - Chemotherapy Phase	9	42	9

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03783949/events

API reference For AI assistants

Adverse events558

Sources 3

Read this list from software.